Estimating hypertrophic cardiomyopathy genotype pre-test probability: an online calculator

18 May 2025 (11:00 - 12:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Mr Paul Kopp

Stony Brook (United States of America)

7 More presentations in this session

Presentation thumbnail

Recognizing red flags: don't judge a book by its cover. data from a multicentric nationwide study

Doctor A. Pinho (Porto, PT)

Abstract Slides Video

Presentation thumbnail

Mavacamten use in a real-world cohort of obstructive hypertrophic cardiomyopathy patients: insights from the initial centre experience

Doctor M. Lima (Lisbon, PT)

Abstract Slides Video

Presentation thumbnail

Differentiating clinical trial endpoints in transthyretin cardiac amyloidosis is significantly improved with continuing medical education

Doctor C. Rohani-Montez (London, GB)

Abstract Slides Video

Presentation thumbnail

Effect of TTR stabilisers on strain values derived by echocardiography in patients with wild type ATTR Amyloidosis

Doctor J. Westphal (Jena, DE)

Abstract Slides Video

Presentation thumbnail

Changes in global myocardial work indices during mavacamten treatment in obstructive hypertrophic cardiomyopathy

Professor R. Sepp (Szeged, HU)

Abstract Slides Video

Access the full session

Session thumbnail

ePosters in myocardial disease - hypertrophic cardiomyopathy (2)

The Event

Event poster

Heart Failure 2025

18 May 2025 11:00 CET

You may be interested in

Congress Presentation

Genetic testing in hypertrophic cardiomyopathy: for all or just selected patients?

Congress Presentation

How should genetics inform the treatment of hypertrophic cardiomyopathies?

Congress Presentation

Enhancement of the Mayo Clinic Genotype Predictor Score using Cardiac MRI

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources